| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of XPC mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of XPC mRNA | CTD | PMID:19428948 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of XPC mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of XPC mRNA | CTD | PMID:17942748 |
| 2-acetamidofluorene | decreases response to substance | EXP | | 6480464 | XPC protein results in decreased susceptibility to 2-Acetylaminofluorene | CTD | PMID:23153559 |
| 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | ISO | RGD:1313986 | 6480464 | [3,4,5,3',4'-pentachlorobiphenyl co-treated with Benzo(a)pyrene] results in decreased expression of XPC protein | CTD | PMID:19553035 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:1313986 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of XPC mRNA | CTD | PMID:12419474 |
| aflatoxin B1 | affects expression | ISO | RGD:1313986 | 6480464 | Aflatoxin B1 affects the expression of XPC protein | CTD | PMID:20106945 |
| aflatoxin B1 | increases expression | ISO | RGD:1313986 | 6480464 | Aflatoxin B1 results in increased expression of XPC mRNA | CTD | PMID:21641981 |
| arsenic atom | affects expression | ISO | RGD:1313986 | 6480464 | Arsenic affects the expression of XPC | CTD | PMID:21235219 |
| ascaridole | affects response to substance | ISO | RGD:1313986 | 6480464 | XPC protein affects the susceptibility to ascaridole | CTD | PMID:22280988 |
| benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of XPC mRNA | CTD | PMID:15342939 |
| benzene | decreases expression | ISO | RGD:1313986 | 6480464 | Benzene results in decreased expression of XPC mRNA | CTD | PMID:18724895 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to XPC promoter] | CTD | PMID:19654925 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1313986 | 6480464 | Benzo(a)pyrene results in decreased expression of XPC protein | CTD | PMID:19748547 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of XPC mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | affects response to substance | ISO | RGD:1313986 | 6480464 | XPC polyA tail polymorphism affects the susceptibility to Benzo(a)pyrene | CTD | PMID:15471894 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1313986 | 6480464 | [3,4,5,3',4'-pentachlorobiphenyl co-treated with Benzo(a)pyrene] results in decreased expression of XPC protein | CTD | PMID:19553035 |
| benzo[a]pyrene | affects response to substance | EXP | | 6480464 | XPC protein affects the susceptibility to Benzo(a)pyrene | CTD | PMID:16094661 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of XPC mRNA | CTD | PMID:19428948 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of XPC mRNA | CTD | PMID:20504355 |
| buta-1,3-diene | increases response to substance | EXP | | 6480464 | XPC gene mutant form results in increased susceptibility to 1,3-butadiene | CTD | PMID:16730686 |
| carboplatin | decreases response to substance | EXP | | 6480464 | XPC results in decreased susceptibility to Carboplatin | CTD | PMID:19372135 |
| chloroethene | affects response to substance | ISO | RGD:1313986 | 6480464 | XPC gene polymorphism affects the susceptibility to Vinyl Chloride | CTD | PMID:21216194 |
| cisplatin | increases expression | ISO | RGD:1313986 | 6480464 | Cisplatin results in increased expression of XPC mRNA | CTD | PMID:21532991 |
| cisplatin | increases expression | ISO | RGD:1313986 | 6480464 | Cisplatin results in increased expression of XPC protein | CTD | PMID:21742020 PMID:22331493 |
| cisplatin | affects response to substance | ISO | RGD:1313986 | 6480464 | XPC protein affects the susceptibility to Cisplatin | CTD | PMID:22331493 |
| cisplatin | multiple interactions | ISO | RGD:1313986 | 6480464 | sodium arsenite inhibits the reaction [Cisplatin results in increased expression of XPC protein]; more ... | CTD | PMID:22331493 |
| cisplatin | increases response to substance | ISO | RGD:1313986 | 6480464 | XPC protein results in increased susceptibility to Cisplatin | CTD | PMID:21324906 |
| cisplatin | decreases response to substance | ISO | RGD:1313986 | 6480464 | XPC protein results in decreased susceptibility to Cisplatin | CTD | PMID:21327329 |
| cisplatin | multiple interactions | ISO | RGD:1313986 | 6480464 | RAD23B mutant form inhibits the reaction [Cisplatin results in increased expression of XPC protein] | CTD | PMID:21742020 |
| cisplatin | increases expression | ISO | RGD:1313986 | 6480464 | Cisplatin results in increased expression of XPC protein | CTD | PMID:21742020 |
| cisplatin | multiple interactions | ISO | RGD:1313986 | 6480464 | Cisplatin inhibits the reaction [Piroxicam results in decreased expression of XPC mRNA] | CTD | PMID:21858171 |
| copper atom | multiple interactions | EXP | | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of XPC mRNA | CTD | PMID:15467011 |
| copper(0) | multiple interactions | EXP | | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of XPC mRNA | CTD | PMID:15467011 |
| cyclophosphamide | affects expression | ISO | RGD:1305760 | 6480464 | Cyclophosphamide affects the expression of XPC mRNA | CTD | PMID:11056294 |
| cyclosporin A | decreases response to substance | EXP | | 6480464 | XPC protein results in decreased susceptibility to Cyclosporine | CTD | PMID:23153559 |
| diarsenic trioxide | affects response to substance | ISO | RGD:1313986 | 6480464 | XPC protein affects the susceptibility to arsenic trioxide | CTD | PMID:20403967 |
| diarsenic trioxide | affects response to substance | ISO | RGD:1313986 | 6480464 | XPC protein affects the susceptibility to arsenic trioxide | CTD | PMID:20403967 PMID:22280988 |
| dibutyl phthalate | decreases expression | ISO | RGD:1305760 | 6480464 | Dibutyl Phthalate results in decreased expression of XPC mRNA | CTD | PMID:21266533 |
| diethylstilbestrol | decreases response to substance | EXP | | 6480464 | XPC protein results in decreased susceptibility to Diethylstilbestrol | CTD | PMID:23153559 |
| furan | decreases expression | ISO | RGD:1305760 | 6480464 | furan results in decreased expression of XPC mRNA | CTD | PMID:22507866 |
| hydroxyurea | increases expression | ISO | RGD:1313986 | 6480464 | Hydroxyurea results in increased expression of XPC mRNA | CTD | PMID:18647660 |
| imiquimod | increases expression | EXP | | 6480464 | imiquimod results in increased expression of XPC mRNA | CTD | PMID:21878529 |
| paracetamol | increases expression | ISO | RGD:1313986 | 6480464 | Acetaminophen results in increased expression of XPC mRNA | CTD | PMID:22230336 |
| pirinixic acid | multiple interactions | ISO | RGD:1313986 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of XPC mRNA | CTD | PMID:19710929 |
| pirinixic acid | affects response to substance | EXP | | 6480464 | XPC protein affects the susceptibility to pirinixic acid | CTD | PMID:23153559 |
| piroxicam | multiple interactions | ISO | RGD:1313986 | 6480464 | Cisplatin inhibits the reaction [Piroxicam results in decreased expression of XPC mRNA] | CTD | PMID:21858171 |
| piroxicam | decreases expression | ISO | RGD:1313986 | 6480464 | Piroxicam results in decreased expression of XPC mRNA | CTD | PMID:21858171 |
| quercetin | increases expression | ISO | RGD:1305760 | 6480464 | Quercetin results in increased expression of XPC mRNA | CTD | PMID:17103110 |
| quercetin | affects response to substance | ISO | RGD:1313986 | 6480464 | XPC protein affects the susceptibility to Quercetin | CTD | PMID:22280988 |
| quercetin | increases expression | ISO | RGD:1313986 | 6480464 | Quercetin results in increased expression of XPC mRNA | CTD | PMID:21632981 |
| scopoletin | affects response to substance | ISO | RGD:1313986 | 6480464 | XPC protein affects the susceptibility to Scopoletin | CTD | PMID:22280988 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of XPC mRNA | CTD | PMID:17484886 |
| valproic acid | multiple interactions | ISO | RGD:1313986 | 6480464 | Valproic Acid promotes the reaction [CREB1 protein binds to XPC promoter]; more ... | CTD | PMID:21507255 |
| valproic acid | increases expression | ISO | RGD:1313986 | 6480464 | Valproic Acid results in increased expression of XPC mRNA | CTD | PMID:21507255 |
| zidovudine | decreases response to substance | ISO | RGD:1313986 | 6480464 | XPC protein results in decreased susceptibility to Zidovudine | CTD | PMID:21192964 |
| zidovudine | increases expression | ISO | RGD:1313986 | 6480464 | Zidovudine results in increased expression of XPC mRNA; more ... | CTD | PMID:21192964 |